Biotech | April 05, 2022
Good business performance gives Boehringer Ingelheim tailwind for investment in R&D
R&D investment up 11.7% to 4.1 billion EUR in 2021 (20.0% of net sales)
R&D investment up 11.7% to 4.1 billion EUR in 2021 (20.0% of net sales)
Sanofi’s DE&I Board will include three of the most influential voices in the DE&I space as Board members appointed for 3 years: organizational psychologist & best-selling author John Amaechi, award-winning social entrepreneur Caroline Casey, and DE&I pioneer and renowned thought-leader Dr. Rohini Anand
Company announced that it is accelerating its investment in its Leaps by Bayer impact investment unit with more than 1.3 billion euros funding until end of 2024
Through this new set-up, the company intends to make available, affordable high-quality medical diagnostic imaging equipment across Tier 2, 3, and 4 towns in India
Arzeda harnesses the power of computer-designed enzymes and applies the latest advances in digital biology
It paves the way for an industry Code of Good Practice
Air purification system achieves Intertek zero ozone certification
New collaboration will help customers reach sustainability goals for high-performance Udel PSU polymers in demanding applications.
The new glass-free detector has improved durability, is more reliable, and has an improved rugged design to sustain in a high workload environment
The next-gen logistics management solutions are making the global supply chains more customer-centric and sustainable
Subscribe To Our Newsletter & Stay Updated
